ABSTRACT ID HALL TIME SLOT TITLE PRESENTER NAME
BHC-13 A 09:00 AM - 09:10 AM MECHANISTIC DETAILING OF COAGULATION FACTOR XIII STRUCTURE SNEHA SINGH
BHC-20 A 09:10 AM - 09:20 AM SIGNIFICANCE OF MIXING STUDY IN LUPUS ANTICOAGULANT AND VARIOUS FORMULAE USED TO INTERPRET RESULTS MAITREYI PATWARDHAN
BHC-25 A 09:20 AM - 09:30 AM APPLICATION AND ADHERENCE OF DEEP VEIN THROMBOSIS (DVT) PROPHYLAXIS RISK ASSESSMENT MODEL IN ICU PATIENTS IN A TERTIARY CARE HOSPITAL JUILEE CHARMODE
BHC-27 A 09:30 AM - 09:40 AM ONE STAGE FVIII ASSAY FOR LABORATORY MONITORING OF EXTENDED HALF-LIFE FACTORS IN HEMOPHILIA A: CHALLENGES AND SOLUTIONS. BIPIN KULKARNI
BHC-30 A 09:40 AM - 09:50 AM PREVALENCE OF ALLOIMMUNISATION IN BETA THALASSEMIA MAJOR AT TERTIARY CARE CENTER PRIYA BORKAR
BHC-40 A 09:50 AM - 10:00 AM EFFICACY AND SAFETY OF MIM8 PROPHYLAXIS IN ADULTS AND ADOLESCENTS WITH HEMOPHILIA A WITH OR WITHOUT INHIBITORS: PHASE 3, OPEN LABEL, RANDOMIZED, CONTROLLED FRONTIER2 STUDY NITA RADHAKRISHNAN
BHL-10 B 09:00 AM - 09:10 AM UNACCEPTABLE RESULTS FOR MICROSCOPIC PERIPHERAL SMEAR EXAMINATION : A PARTICIPATING LABORATORY ANALYSIS. RAJESHWARI HANDIGUND
BHL-13 B 09:10 AM - 09:20 AM BORDERLINE HBA2 LEVELS: ARE WE MISSING SOMETHING? SHALINI SINGH
BHL-14 B 09:20 AM - 09:30 AM LIKELIHOOD OF IDENTIFYING A HLA-MATCHED RELATED OR UNRELATED DONOR FOR INDIAN PATIENTS SEEKING STEM CELL TRANSPLANTATION SUREKA RAJENDRAN
BHL-18 B 09:30 AM - 09:40 AM STRATEGIES FOR SMALL LABORATORIES THAT ARE ECONOMICAL IN TERMS OF INTERNAL QUALITY CONTROL KALPESH GOLVANKAR
BHL-19 B 09:40 AM - 09:50 AM PREVALENCE OF KIR-B HAPLOTYPE AND KIR ALLOREACTIVITY IN DONORS OF HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION: A SINGLE CENTER STUDY FROM INDIA KANISHKA CHAURASIA
BHL-21 B 09:50 AM - 10:00 AM COMPARING THE DIAGNOSTIC ACCURACY OF DETECTING RED BLOOD CELLS IN URINE USING LIGHT MICROSCOPIC EXAMINATION, PHASE CONTRAST MICROSCOPIC EXAMINATION AND AN AUTOMATED URINE ANALYSER PRERNA PRASAD
MHC-12 C 09:00 AM - 09:10 AM TREATMENT OUTCOME IN ADOLESCENT AND YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) ON BFM-95 PROTOCOL: EXPERIENCE OF A TERTIARY CARE INSTITUTE FROM NORTH INDIA. ALPIKA SHUKLA
MHC-13 C 09:10 AM - 09:20 AM OUTCOMES OF DLBCL TREATED FROM 2011 TO 2020: AN AUDIT FROM AN EASTERN INDIA TERTIARY CANCER CENTER. SREYA DAS
MHC-14 C 09:20 AM - 09:30 AM YOUNG PATIENTS WITH DLBCL IN INDIA: INITIAL 1-YEAR OUTCOMES REVEAL AGGRESSIVE DISEASE AND FAVORABLE RESPONSES DESPITE HIGH LOSS TO FOLLOW-UP SUVIR SINGH
MHC-16 C 09:30 AM - 09:40 AM OUTCOMES IN ADULT HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) WITH LOW DOSE CYCLOPHOSPHAMIDE: A SINGLE CENTRE PILOT STUDY SUSHMA BAISHYA
MHC-17 C 09:40 AM - 09:50 AM FLAT-DOSE NIVOLUMAB-BASED COMBINATION REGIMENS FOR TREATMENT OF RELAPSE REFRACTORY HODGKIN LYMPHOMA : REAL-WORLD EVIDENCE FROM A LOWER MIDDLE-INCOME COUNTRY NIHAR DESAI
MHC-18 C 09:50 AM - 10:00 AM FEASIBILITY OF AZACITIDINE AND VENETOCLAX FOLLOWED BY HIGH/INTERMEDIATE DOSE CYTARABINE (HIDAC/IDAC) CONSOLIDATION IN PREVIOUSLY UNTREATED ACUTE MYELOID LEUKEMIA PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY - A AMIYA RANJAN NAYAK
MHL-7 D 09:00 AM - 09:10 AM TRBC1 AS A SURROGATE MARKER FOR CLONALITY IN TCR ALPHA/BETA POSITIVE T-CELL NEOPLASM BY MULTICOLOUR FLOWCYTOMETRY. SUBHAJIT BRAHMA
MHL-8 D 09:10 AM - 09:20 AM THE BIOPSY PRESENTATION OF ACUTE LYMPHOBLASTIC LEUKEMIA AND ITS CORRELATION WITH CLINICAL OUTCOMES SHAURYA VIJAYRAN
MHL-9 D 09:20 AM - 09:30 AM EXPRESSION OF CD304 IN PEDIATRIC B CELL ACUTE LYMPHOBLASTIC LEUKAEMIA AND ITS ROLE IN MEASURABLE RESIDUAL DISEASE (MRD) MONITORING NEHA .
MHL-10 D 09:30 AM - 09:40 AM IMMUNOHISTOCHEMICAL EXPRESSION OF MUTANT NPM1 IN ADULT ACUTE MYELOID LEUKEMIA S R DEEPA
MHL-11 D 09:40 AM - 09:50 AM THE GENETIC CHARACTERIZATION AND OUTCOME ANALYSIS OF ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE : A GRAY ZONE ENTITY AMRITHA SARAVANAN
MHL-12 D 09:50 AM - 10:00 AM CORRELATION OF CYTOGENETIC ABERRATIONS WITH CLINICAL CHARACTERISTICS AND TREATMENT OUTCOME IN MULTIPLE MYELOMA KRUTI CHAUBAL
MH-2 E 09:00 AM - 09:08 AM CLINICO-HEMATOLOGICAL PROFILES OF MYELODYSPLASIA RELATED MUTATIONS IN ACUTE MYELOID LEUKEMIAS. PRAKHAR GUPTA
MH-3 E 09:08 AM - 09:16 AM NOT EVERYTHING HAIRY IS A HAIRY CELL - EVADING THE TRAP, A CASE SERIES OF SEVEN CASES MOHAMMED N MEERA
MH-4 E 09:16 AM - 09:24 AM QUANTITATION OF LEUKEMIC STEM CELL-LIKE CELLS (LSC) BURDEN AT DIAGNOSIS IDENTIFIES CLINICAL HETEROGENEITY IN EUROPEAN LEUKEMIANET 22 (ELN22) RISK STRATIFICATION OF ACUTE MYELOID LEUKEMIA (AML) AARTI ACHREKAR
MH-5 E 09:24 AM - 09:32 AM MOLECULAR CHARACTERISATION OF BETA-THALASSEMIA IN ANTENATAL SCREENING SAMPLES AT A TERTIARY CARE CENTRE IN CENTRAL INDIA DIVYANSHI GARKOTI
MH-6 E 09:32 AM - 09:40 AM MOLECULAR WORK UP OF UNEXPLAINED ERYTHROCYTOSIS IN YOUNG PATIENTS OF INDIAN ORIGIN, A STUDY CONDUCTED AT TERTIARY CENTRE IN NORTH INDIA. PRATYUSHA GUDAPATI
MH-7 E 09:40 AM - 09:48 AM IMPACTS OF WT1 GENE GENOMIC AND EPIGENOMIC ABERRATIONS ON PROGNOSIS IN ACUTE MYELOID LEUKEMIA WITHIN THE INDIAN POPULATION EKTA RAHUL
BHL-32 E 09:48 AM - 09:56 AM THE SPURIOUSLY HIGH NEUTROPHIL CELL COUNTER POPULATION DATA IN APML- A CASE SERIES SNEHIL KUMAR
BHL-30 E 09:56 AM - 10:04 AM PROGNOSTIC CORRELATIONAL STUDY OF HEMOGLOBIN INDICES WITH RISING MELD SCORES VIRENDRA BHAD
BHL-28 E 10:04 AM - 10:12 AM SPECTRUM OF HAEMOGLOBINOPATHIES IN ANTENATAL WOMEN IN A TERTIARY CARE CENTRE. DAMINI SAINI
BHL-22 E 10:12 AM - 10:20 AM TITLE: COMPARISON OF IMMATURE PLATELET FRACTION (IPF) BETWEEN NORMOTENSIVE AND PRE-ECLAMPTIC PREGNANT FEMALES SONALIKA PRIYADARSHINI SAHOO
BHL-20 E 10:20 AM - 10:28 AM EXPERIENCE OF NEW BORN SCREENING FOR HEMOGLOBINOPATHIES AT TERTIARY CARE CENTER IN VIDARBHA OVER 18 MONTHS: IDENTIFYING CHALLENGES AND SOLUTIONS APURVA RAMTEKE
BHL-17 E 10:28 AM - 10:36 AM BONE MARROW GRANULOMAS - INSIGHTS AND IMPLICATIONS. GURPREET KAUR
BHL-12 E 10:36 AM - 10:44 AM IMMUNOPHENOTYPIC PROFILE IN A PEDIATRIC PATIENT MIMICKING MALIGNANT LYMPHOPROLIFERATIVE DISORDER SAVITRI SINGH
BHL-33 E 10:44 AM - 10:52 AM PRP CLOUD: NO SURGERY SOLUTION FOR KNEE OSTEOARTHRITIS: A REVOLUTIONARY GAME CHANGER AKASH SAOLI
BHC-1 E 06:30 PM - 06:38 PM PERFORMANCE CHARACTERISTICS OF % HYPOCHROMIC RED CELLS IN THE DETECTION OF LATENT IRON DEFICIENCY IN WOMEN WITH MENOMETRRORHAGIA VIVEK GEORGE
BHC-2 E 06:38 PM - 06:46 PM INTEGRATING CLINICAL FEATURES AND GENETIC FACTORS WITH BLOOD COMPONENT USE IN ACUTE LEUKEMIA SANKALP SHARMA
BHC-4 E 06:46 PM - 06:54 PM LOW HEMOGLOBIN IS NOT ALWAYS IRON DEFICIENCY ANEMIA. AT LEAST IN NILGIRIS, TAMIL NADU ANCY ABRAHAM
BHC-6 E 06:54 PM - 07:02 PM EFFICACY OF ROMIPLOSTIM IN NEWLY DIAGNOSED APLASTIC ANAEMIA. MADHUPRIYA B
BHC-7 E 07:02 PM - 07:10 PM RETICULOCYTE HEMOGLOBIN: A NOVEL PARAMETER FOR DETECTING IRON REPLETE STATUS AMONG REGULAR FEMALE BLOOD DONORS DIVYA T
BHC-8 E 07:10 PM - 07:18 PM CLINICAL PROFILE OF INHERITED PLATELET DISORDERS IN CHILDREN: A SINGLE CENTRE RETROSPECTIVE STUDY ANWESHA SINGH
BHC-14 E 07:18 PM - 07:26 PM BLOOD GROUP DISTRIBUTION PATTERNS IN VOLUNTARY BLOOD DONORS- AN OBSERVATIONAL STUDY ADITYA RANE
MHC-9 E 07:26 PM - 07:34 PM REAL-WORLD EXPERIENCE WITH GENERIC VENETOCLAX PLUS HYPOMETHYLATING AGENT INDUCTION THERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS IN RESOURCE-LIMITED SETTING: A SINGLE-CENTER STUDY FROM AIIMS ARJUN ARJUN
MHC-32 E 07:34 PM 07:42 PM RETROSPECTIVE ANALYSIS OF OUTCOMES OF 7-DAY COURSE OF VENTOCLAX WITH HYPOMETHYLATING AGENT IN NEWLY DIAGNOSED PATIENTS OF AML : SINGLE CENTRE EXPERIENCE BHAVANI MANDAVA